Brenda Young experienced takotsubo cardiomyopathy, or broken heart syndrome, after witnessing her mother’s death in November ...

On paper, I have insurance coverage. In real life, I don’t have access. That’s what I call ‘ghost approval,’” writes patient ...

Elin Lewis, a 12-year-old girl from Greenwood, has made history as the first patient in the state to receive a groundbreaking ...

Mayo Clinic researchers report that a highly targeted, noninvasive form of radiation therapy reduced episodes of a life-threatening heart rhythm disorder by nearly 80% in a first-in-human early ...

The role of long-term beta-blocker therapy after a myocardial infarction in patients without left ventricular systolic dysfunction or heart failure is unclear in the era of contemporary ...

A large VHA real-world analysis compared GLP‑1 receptor agonists (~132,000) with sulfonylureas (>201,000), focusing on major adverse cardiovascular outcomes in type 2 diabetes. Continuous GLP‑1 ...

For a heart just damaged by a blocked artery, timing matters. So does access. That is what makes a new experimental treatment stand out: instead of being delivered directly to the heart, it is ...

Advisors using fintech Altruist’s AI-powered Hazel platform are bullish on the technology’s power to boost their business. “The hype is real,” says one advisor. Financial advisor Douglas Boneparth ...

Altruist is adding tax planning to its Hazel AI platform, giving advisors another way to push routine analysis and documentation into software as tax season ramps up. The Los Angeles-based RIA ...

Altruist has launched artificial intelligence-powered tax planning within Hazel, its AI platform, enabling advisors to create personalized tax strategies by analyzing clients’ 1040s, pay stubs, ...

PORTLAND, Ore. (KPTV) - February is Heart Health Month, a time to raise awareness about heart disease and its causes, especially in women. Nearly 45% of women age 20 and older are living with some ...

A UC San Diego–led team has discovered that restoring a key cardiac protein called connexin‑43 in a mouse model can dramatically improve heart function and extend survival in several inherited forms ...